Log In
BCIQ
Print this Print this
 

Motiva, Nefiracetam, N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionCyclic GABA derivative
Molecular Target
Mechanism of ActionGABA receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat post-stroke depression and apathy
Regulatory Designation
PartnerNeuren Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today